Drug intelligence / Profile preview

tocovid

Development stage
Phase 4
Lead developer
Hovid
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Oral
01

Overview

Tocovid is a branded formulation of tocotrienol-rich vitamin E derived from palm oil. It contains a mixture of tocotrienols (d-alpha, d-gamma, d-delta) and alpha-tocopherol. Tocovid acts primarily as an antioxidant and has demonstrated anti-inflammatory properties. Clinical studies suggest it may ameliorate diabetic nephropathy by reducing serum creatinine and advanced glycation end products (AGEs), as well as improve nerve conduction in diabetic peripheral neuropathy by increasing nerve growth factor levels[1][4]. Additional indications include cardiovascular support through cholesterol management, neuroprotection for cognitive function maintenance, skin health benefits, and general wellness[5][6][9]. The product is available in softgel or tablet form and is classified as an over-the-counter dietary supplement or multivitamin/antioxidant in several markets[8][10].

Brand names
TocovidTocovid SupraBioTocovid Promemo
Other names
tocotrienol-rich vitamin E from palm oilmixed tocotrienols (from palm oil)multivitamins (as per regulatory filings)
02

Targets

AGER (RAGE)

Beyond the preview

Go deeper on tocovid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tocovid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call